References
- Freeman J, Nelson K Intrapartum asphyxia and cerebral palsy. Pediatrics 1988;82:240–249.
- Blair E, Stanley F. Intrapartum asphyxia: A rare cause of cerebral palsy. J Pediatr 1988;112:515–519.
- Clapp JF, Peress NS, Wesley M, et al. Brain damage after intermittent partial cord occlusion in the chronically instru-mented fetal lambs. Am J Obstet Gynecol 1988;159:504–509.
- De Haan HH, Gunn AJ, Williams CE, et al. Brief repeated umbilical cord occlusions cause sustained cytotoxic cerebral edema and focal infarcts in near-term fetal lambs. Pediatr Res 1997;41:96–104.
- Masaoka N, Hayakawa Y, Ohgame S, et al. Changes in purine metabolism and production of oxygen free radicals by intermittent partial umbilical cord occlusion in chronically instrumented fetal lambs. J Obstet Gynecol Res 1998;24:63–71.
- Palmer C. Hypoxic-ischemic encephalopathy: Therapeutic approaches against microvascular injury, and role of neutro-phils, PAF, and free radicals. Chin Perinatol 1995;22:481–517.
- Pourcyrous M, Leffler CW, Bada HS, et al. Brain superoxide anion generation in asphyxiated piglets and the effect of indomethacin at therapeutic dose. Pediatr Res.1993;34:366–369.
- Betz AL. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J Neurochem 1985;44:574–579.
- Gluckman PD, Williams CE. Is the cure worse than the disease? Caveats in the move from laboratory to clinic. Dev Med Child Neurol 1992;34:1015–1018.
- Palmer C, Vanucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990;27:332–336.
- Palmer C, Smith MB, Williams CD, et al. Allopurinol preserves cerebral energy metabolism during perinatal hy-poxic-ischemic injury and reduces brain damage in a dose dependent manner. J Cereb Blood Flow Metab 1991; 11:S144–S149.
- Moonhouse PC, Grootvelt M, Halliwell B, et al. Allopurinol and oxypurinol are hydroxyl radical scavenger. FEBS Lett 1987;21:23–28.
- Ko KM, Godin DV. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 1990;40: 803–809.
- Boda D, Nemeth I, Hencz P, et al. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Dev Pharmacol Ther 1984;7:357–367.
- Russel GAB., Cooke RWI. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Chi1d1995;73:F27–F31.
- Marro PJ, Baumgart S, Delivoria-Papadopoulas M, et al. Purine metabolism and inhibition of xanthine oxidase in severly hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatr Res 1997;41:513–520.
- Palmer C, Towfighi J, Roberts SL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces injury in 7-day-old rats. Pediatr Res1993;33:405–409.
- Palmer C, Roberts RL. Delayed administration of allopurinol after cerebral hypoxia-ischemia reduced brain injury in neonatal rats. Pediatr Res 1994;41:294A.
- Frank VB, Majidah S, Ralf MW, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185–193.
- Shadis M, Moison R, Steendijk P, et al. The effect of antioxidative combination therapy on post hypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain. Pediatr Res; 44:119–124.
- Marron PJ, Hoffmann D, Schneiderman R, et al. Effect of allopurinol on NMDA receptor modification following recurrent asphyxia in newborn piglets. Brain Res 1998;16:71–77.
- Shadid M, Buonocore G, Groenendaal F, et al. Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci Lett 1988;22:5–8.
- Marro PJ, Anderson CB, Mishra OP, et al. Effect of allopurinol on hypoxia-induced modification of the NMDA receptor in newborn piglets. Neurochem Res 1999;24:1301–1306.
- Whitelaw A. Systematic review of therapy after hypoxic-ischemic brain injury in the perinatal period. Semin Neonatol 2000;5:33–40.
- Terzi C, Kuzu A, Asiar AK, et al. Prevention of deleterious effects of reperfusion injury using one-week high-dose allopurinol. Dig Dis Sci 2001;46:430–437.
- Akdemir H, Asik Z, Pasaoglu H, et al. The effect of allopurinol on focal cerebral ischemia: An experimental study in rabbits. Neurosurg Rev 2001;24:131–135.
- Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 2002;9:195–217.
- Peeters-Scholte C, Vant Den Tweel E, Iorol T. et al. Pharmacological interventions in the newborn piglet in the first 24 h after hypoxia-ischemia: A hemodynamic and eletrophysiological perspective. Exp Brain Res 2002;147: 200–208.
- Whitelaw A, Thoresen M. Clinical trial of treatment after perinatal asphyxia. Curr Opin Pediatr 2002;14:664–668.
- Kann HE, Wells JH, Galleli JF, et al. The development and use of an intravenous preparation of allopurinol. Am J Med Sci 1968;256:53–63.
- Saliba E, Marret S. Cerebral white matter damage in the preterm infant: Pathophysiology and risk factors. Semin Neonatol 2001;6:121–133.
- Takashima S, Tanaka K. Development of cerebrovasucular architecture and its relationship to periventricular leukomala-cia. Arch Neurol 1995;35:11–16.